Harvard Prof Says Novo's Influence Didn't Boost Prescriptions
By Ben Adlin · November 3, 2025, 10:22 PM EST
A Harvard Medical School professor defended Novo Nordisk on Monday against allegations that it defrauded Washington state's Medicaid system by inducing doctors to overprescribe its hemophilia medication NovoSeven, testifying that his...
To view the full article, register now.